The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Reardon Tighe since 2018.
This trader's CIK number is 1760431.
At the time of last reporting, Reardon Tighe was the Acting Chief Financial Officer of Janux Therapeutics, Inc.. (stock ticker symbol JANX).
Also see all insider trading activities at Janux Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | JANX | 0 | $0 | 822,721 | $45,043,974 | 0 | $0 |
| 2023 | JANX | 849,854 | $4,988,642 | 0 | $0 | 0 | $0 |
| 2021 | JANX | 629,411 | $10,699,987 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | THOR | 545,455 | $6,000,005 | 0 | $0 | 0 | $0 |
1. Janux Therapeutics, Inc. (JANX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-06-03 | JANX | Sale | 822,721 | 54.75 | 45,043,974 |
| 2023-11-13 | JANX | Buy | 849,854 | 5.87 | 4,988,642 |
| 2021-06-15 | JANX | Buy | 629,411 | 17.00 | 10,699,987 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-12-11 | THOR | Buy | 545,455 | 11.00 | 6,000,005 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Reardon Tighe (Acting Chief Financial Officer of Janux Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.